Synthekine

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• 15 Sept 2026Biased IL2 Muteins Methods And Compositionsgranted
• 30 Jul 2026Heterodimeric Fc Cytokines And Uses Thereofapplication
• 28 Jul 2026IL12RB2 Binding Molecules And Methods Of Usegranted
• 21 Jul 2026IL2 Muteinsgranted
• 25 Jun 2026GP130 Binding Molecules And Methods Of Useapplication
• 03 Feb 2026IL10Ra/IL2Ry SYNTHETIC CYTOKINESgranted
• 13 Jan 2026Heterodimeric Fc Cytokines And Uses Thereofgranted
• 25 Dec 2025Human IL-12P40 Variants And Uses Thereofapplication
• 18 Dec 2025Orthogonal GPC3 Chimeric Antigen Receptor T Cellsapplication
• 11 Dec 2025Compositions And Methods Related To Receptor Pairingsapplication
• 06 Nov 2025Compositions And Methods Related To Receptor Pairingsapplication
• 30 Oct 2025IL10RB Binding Molecules And Encoding Nucleic Acidsapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.